In the present study, we found that Bbf2h7 expression levels significantly increased by 1.070–2.567-fold in several tumor types including glioblastoma compared with those in respective normal tissues, using the ONCOMINE Cancer Profiling Database. This evidence concerns the gene CREB3L2 and glioblastoma.